ABBVIE INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.05 USD | +4.64% |
|
+6.18% | +18.75% |
| 28/06 | Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU | MT |
| 28/06 | AbbVie, Genmab Receive Positive European Opinion on Marketing Authorization for Possible Lymphoma Treatment | MT |
